tiprankstipranks
Trending News
More News >
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market
Advertisement

Sonoma Pharmaceuticals (SNOA) Income Statement

Compare
321 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q4 2025), Sonoma Pharmaceuticals's total revenue was $3.75M, an increase of 19.63% from the same quarter last year. In Q4, Sonoma Pharmaceuticals's net income was $-776.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 14.29M$ 12.73M$ 13.27M$ 12.63M$ 18.63M
Gross Profit
$ 5.46M$ 4.75M$ 4.48M$ 3.99M$ 6.56M
Operating Expenses
$ 9.18M$ 9.45M$ 9.05M$ 9.88M$ 10.01M
Depreciation and Amortization
$ 138.00K$ 176.00K$ 298.00K$ 409.00K$ 227.00K
EBITDA
$ -3.57M$ -4.53M$ -4.45M$ -5.70M$ -3.22M
Operating Income
$ -3.71M$ -4.70M$ -4.57M$ -5.89M$ -3.45M
Other Income/Expenses
$ 803.00K$ -330.00K$ -614.00K$ 469.00K$ -453.00K
Pretax Income
$ -2.91M$ -5.03M$ -5.18M$ -5.42M$ -3.90M
Net Income
$ -3.46M$ -4.83M$ -5.15M$ -5.09M$ -4.62M
Per Share Metrics
Basic EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Diluted EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Weighted Average Shares Outstanding
1.24M 909.00K 339.40K 265.30K 199.60K
Weighted Average Shares Outstanding (Diluted)
1.24M 909.00K 339.40K 265.30K 199.60K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis